216 related articles for article (PubMed ID: 18269585)
1. Clinical role of flow cytometry in redefining bone marrow involvement in diffuse large B-cell lymphoma (DLBCL) - a new perspective.
Talaulikar D; Shadbolt B; Bell J; Khan K; Dahlstrom JE; McDonald A; Pidcock M; Broomfield A
Histopathology; 2008 Feb; 52(3):340-7. PubMed ID: 18269585
[TBL] [Abstract][Full Text] [Related]
2. Occult bone marrow involvement in patients with diffuse large B-cell lymphoma: results of a pilot study.
Talaulikar D; Dahlstrom JE; Shadbolt B; McNiven M; Broomfield A; Pidcock M
Pathology; 2007 Dec; 39(6):580-5. PubMed ID: 18027262
[TBL] [Abstract][Full Text] [Related]
3. Flow cytometry in the bone marrow evaluation of follicular and diffuse large B-cell lymphomas.
Palacio C; Acebedo G; Navarrete M; Ruiz-Marcellán C; Sanchez C; Blanco A; López A
Haematologica; 2001 Sep; 86(9):934-40. PubMed ID: 11532621
[TBL] [Abstract][Full Text] [Related]
4. Clinical utility of bone marrow flow cytometry in B-cell non-Hodgkin lymphomas (B-NHL).
Perea G; Altés A; Bellido M; Aventín A; Bordes R; Ayats R; Remacha AF; Espinosa I; Briones J; Sierra J; Nomdedéu JF
Histopathology; 2004 Sep; 45(3):268-74. PubMed ID: 15330805
[TBL] [Abstract][Full Text] [Related]
5. Clinical relevance of immunophenotype in a retrospective comparative study of 297 peripheral T-cell lymphomas, unspecified, and 496 diffuse large B-cell lymphomas: experience of the Intergruppo Italiano Linformi.
Morabito F; Gallamini A; Stelitano C; Callea V; Guglielmi C; Neri S; Lazzaro A; Orsucci L; Ilariucci F; Sacchi S; Vitolo U; Federico M
Cancer; 2004 Oct; 101(7):1601-8. PubMed ID: 15378507
[TBL] [Abstract][Full Text] [Related]
6. Can flow cytometry of bone marrow aspirate predict outcome of patients with diffuse large B cell lymphoma? A retrospective single centre study.
Wolach O; Fraser A; Luchiansky M; Shapiro C; Radnay J; Shpilberg O; Lishner M; Lahav M
Hematol Oncol; 2015 Mar; 33(1):42-7. PubMed ID: 24470400
[TBL] [Abstract][Full Text] [Related]
7. Contribution of flow cytometric immunophenotyping and bone marrow trephine biopsy in the detection of lymphoid bone marrow infiltration in non-Hodgkin's lymphomas.
Mazur G; Hałoń A; Wróbel T; Jeleń M; Kuliczkowski K
Neoplasma; 2004; 51(3):159-63. PubMed ID: 15254666
[TBL] [Abstract][Full Text] [Related]
8. Flow cytometry in the bone marrow staging of mature B-cell neoplasms.
Stacchini A; Demurtas A; Godio L; Martini G; Antinoro V; Palestro G
Cytometry B Clin Cytom; 2003 Jul; 54(1):10-8. PubMed ID: 12827663
[TBL] [Abstract][Full Text] [Related]
9. Morphologic, flow cytometric and cytogenetic evaluation of bone marrow involvement in B-cell lymphoma.
Gomyo H; Shimoyama M; Minagawa K; Yakushijin K; Urahama N; Okamura A; Yamamoto K; Ito M; Chihara K; Hayashi Y; Matsui T
Haematologica; 2003 Dec; 88(12):1358-65. PubMed ID: 14687988
[TBL] [Abstract][Full Text] [Related]
10. Risk factors for poor treatment outcome and central nervous system relapse in diffuse large B-cell lymphoma with bone marrow involvement.
Lee KW; Yi J; Choi IS; Kim JH; Bang SM; Kim DW; Im SA; Kim TY; Yoon SS; Lee JS; Bang YJ; Park S; Kim BK; Cho HI; Heo DS
Ann Hematol; 2009 Sep; 88(9):829-38. PubMed ID: 19172274
[TBL] [Abstract][Full Text] [Related]
11. Minimal residual disease detection in mantle cell lymphoma: methods and significance of four-color flow cytometry compared to consensus IGH-polymerase chain reaction at initial staging and for follow-up examinations.
Böttcher S; Ritgen M; Buske S; Gesk S; Klapper W; Hoster E; Hiddemann W; Unterhalt M; Dreyling M; Siebert R; Kneba M; Pott C;
Haematologica; 2008 Apr; 93(4):551-9. PubMed ID: 18379010
[TBL] [Abstract][Full Text] [Related]
12. The clinical presentation and prognosis of diffuse large B-cell lymphoma with t(14;18) and 8q24/c-MYC rearrangement.
Le Gouill S; Talmant P; Touzeau C; Moreau A; Garand R; Juge-Morineau N; Gaillard F; Gastinne T; Milpied N; Moreau P; Harousseau JL; Avet-Loiseau H
Haematologica; 2007 Oct; 92(10):1335-42. PubMed ID: 18024371
[TBL] [Abstract][Full Text] [Related]
13. Bone marrow staging of patients with non-Hodgkin lymphoma by flow cytometry: correlation with morphology.
Duggan PR; Easton D; Luider J; Auer IA
Cancer; 2000 Feb; 88(4):894-9. PubMed ID: 10679660
[TBL] [Abstract][Full Text] [Related]
14. [The value of multiparameter flow cytometry in diagnosis of lymphocytic leukemia and bone marrow involvement of non-Hodgkin's lymphoma].
Sun XF; He LR; Feng HL; Yan SL; Xia ZJ; Chen XQ
Ai Zheng; 2003 Nov; 22(11):1232-6. PubMed ID: 14613660
[TBL] [Abstract][Full Text] [Related]
15. The prognostic impact of bone marrow involvement in patients with diffuse large cell lymphoma varies according to the degree of infiltration and presence of discordant marrow involvement.
Campbell J; Seymour JF; Matthews J; Wolf M; Stone J; Juneja S
Eur J Haematol; 2006 Jun; 76(6):473-80. PubMed ID: 16529599
[TBL] [Abstract][Full Text] [Related]
16. De novo CD5+ diffuse large B-cell lymphoma: results of a detailed clinicopathological review in 120 patients.
Yamaguchi M; Nakamura N; Suzuki R; Kagami Y; Okamoto M; Ichinohasama R; Yoshino T; Suzumiya J; Murase T; Miura I; Ohshima K; Nishikori M; Tamaru J; Taniwaki M; Hirano M; Morishima Y; Ueda R; Shiku H; Nakamura S
Haematologica; 2008 Aug; 93(8):1195-202. PubMed ID: 18556402
[TBL] [Abstract][Full Text] [Related]
17. Prognostic significance of molecular staging by PCR-amplification of immunoglobulin gene rearrangements in diffuse large B-cell lymphoma (DLBCL).
Mitterbauer-Hohendanner G; Mannhalter C; Winkler K; Mitterbauer M; Skrabs C; Chott A; Simonitsch-Klupp I; Gleiss A; Lechner K; Jaeger U
Leukemia; 2004 Jun; 18(6):1102-7. PubMed ID: 15085149
[TBL] [Abstract][Full Text] [Related]
18. Assessment of bone marrow involvement in non-Hodgkin's lymphomas: comparison between histology and flow cytometry.
Merli M; Arcaini L; Boveri E; Rattotti S; Picone C; Passamonti F; Tenore A; Sozzani L; Lucioni M; Varettoni M; Rizzi S; Morello L; Ferretti V; Pascutto C; Paulli M; Lazzarino M
Eur J Haematol; 2010 Nov; 85(5):405-15. PubMed ID: 20662897
[TBL] [Abstract][Full Text] [Related]
19. Primary testicular diffuse large B-cell lymphoma: a population-based study on the incidence, natural history, and survival comparison with primary nodal counterpart before and after the introduction of rituximab.
Gundrum JD; Mathiason MA; Moore DB; Go RS
J Clin Oncol; 2009 Nov; 27(31):5227-32. PubMed ID: 19770371
[TBL] [Abstract][Full Text] [Related]
20. Comparative clinicopathological study of primary CNS diffuse large B-cell lymphoma and intravascular large B-cell lymphoma.
Imai H; Shimada K; Shimada S; Abe M; Okamoto M; Kitamura K; Kinoshita T; Shiraishi T; Nakamura S
Pathol Int; 2009 Jul; 59(7):431-7. PubMed ID: 19563405
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
